McCrossan B A, Karayiannis S, Shields M, Nykanen David, Forbes Thomas J, Kobayashi Daisuke, Kenny D
Dept of Paediatric Cardiology, Royal Belfast Hospital for Sick Children, Belfast, BT12 6BE, Northern Ireland, UK.
Dept of Paediatric Cardiology, Children's Health Ireland, Crumlin, Dublin, Ireland.
Pediatr Cardiol. 2023 Apr;44(4):867-872. doi: 10.1007/s00246-023-03103-2. Epub 2023 Jan 27.
Cardiac perforation is a rare life-threatening complication of cardiac catheterization. There is very little published literature detailing risk factors for cardiac perforation and outcomes from this complication in children.
This was a retrospective study analyzing the cardiac catheterization case registry of the Congenital Cardiovascular Interventional Study Consortium. Children aged < 18 years were included during the study period of 9 years (January 2009-December 2017). The primary outcome measures were incidence of cardiac perforation, risk factors for and outcomes of patients who experience cardiac perforation during cardiac catheterization.
Cardiac perforation occurred in 50 patients from a total of 36,986 (0.14%). Cardiac perforation was more likely to occur in younger, smaller patients undergoing urgent/emergent and interventional procedures (p < 0.01). Cardiac peroration risk was significantly different across diagnostic and procedure categories (p < 0.01). Higher CRISP score (Area Under Curve [AUC] = 0.87), lower age, and procedure category (radiofrequency perforation of pulmonary valve, AUC = 0.84) were independent predictors of cardiac perforation. Cardiac perforation was associated with a significantly higher rate of mortality (14%), further emergency procedure (42%), ECMO (14%), and cardiac arrest (6%), p < 0.01.
Cardiac perforation during cardiac catheterization is a life-threatening complication with a range of associated secondary complications. Higher CRISP score, lower age, and radiofrequency perforation of pulmonary valve are independent predictors.
心脏穿孔是心脏导管插入术罕见的危及生命的并发症。关于儿童心脏穿孔的危险因素及该并发症预后的详细文献报道极少。
这是一项回顾性研究,分析先天性心血管介入研究联盟的心脏导管插入术病例登记资料。研究期间为9年(2009年1月至2017年12月),纳入年龄小于18岁的儿童。主要观察指标为心脏穿孔的发生率、心脏导管插入术期间发生心脏穿孔患者的危险因素及预后。
在总共36986例患者中,有50例发生心脏穿孔(0.14%)。心脏穿孔更易发生于年龄较小、身材较小且接受紧急/急诊及介入手术的患者(p<0.01)。不同诊断和手术类别之间心脏穿孔风险存在显著差异(p<0.01)。较高的CRISP评分(曲线下面积[AUC]=0.87)、较低年龄及手术类别(肺动脉瓣射频穿孔,AUC=0.84)是心脏穿孔的独立预测因素。心脏穿孔与显著更高的死亡率(14%)、进一步的急诊手术(42%)、体外膜肺氧合(ECMO,14%)及心脏骤停(6%)相关,p<0.01。
心脏导管插入术期间的心脏穿孔是一种危及生命的并发症,伴有一系列相关的继发并发症。较高的CRISP评分、较低年龄及肺动脉瓣射频穿孔是独立预测因素。